Reinvigoron TheraTech Inc.

Reinvigoron is a biotechnology company creating systemically-delivered, non-viral DNA therapeutics to treat resistant cancers. To outsmart cancer, we need therapies that combine optimal delivery, exquisite specificity, modularity, and scalable manufacturing. We are pioneering therapeutics that work intracellularly to reprogram cancer cells into biologic drug factories. Using our proprietary technology, we deliver therapeutic genes via tiny nanoparticle carriers - akin to a microscopic trojan horse - that only activate in cancer cells. We are not just targeting cancer; we are transforming it, unlocking the potential to turn the disease against itself and redefine what’s possible in cancer treatment.